Nkarta Announces Key Senior Leadership Team Appointments
Retrieved on:
Monday, July 25, 2022
San Francisco State University, Sale, Certified Public Accountant, University, GLOBE, National Taiwan Normal University, Celera Corporation, University of Basel, Treasury, U.S. Securities and Exchange Commission, Doctor of Philosophy, American Institute, CEO, SEC, CAR, Howard Hughes Medical Institute, Intellectual property, Vienna Biocenter, Compliance, Private Securities Litigation Reform Act, American Institute of Certified Public Accountants, Risk, COVID-19, Baxter International, CRISPR, Cancer, Leadership, University of California, San Francisco, MS, MBA, Cryopreservation, Senior, Security (finance), Patient, OncoMed, NK, Biology, Cell biology, Accounting, Growth, Financial management, Pharmaceutical industry, Management
Ralph and Yvonne have each distinguished themselves through their exceptional accomplishments, leadership of collaborative teams and valuable cross-functional contributions to Nkarta, said Paul J. Hastings, President and CEO of Nkarta.
Key Points:
- Ralph and Yvonne have each distinguished themselves through their exceptional accomplishments, leadership of collaborative teams and valuable cross-functional contributions to Nkarta, said Paul J. Hastings, President and CEO of Nkarta.
- Dr. Brandenberger joined Nkarta in April 2018 and most recently served as Senior Vice President, Technical Operations.
- Ms. Li joined Nkarta in November 2019 as Senior Vice President, Finance to lead the companys financial management, treasury, tax, accounting, and SEC reporting operations.
- Prior to joining Nkarta, she held senior leadership roles in finance, accounting and operations at Amunix and OncoMed.